Timothy P. Coughlin, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 20,000 shares at $21.00 ($430K) on 2014-12-10, disclosed to the SEC on 2014-12-12.
Scheduled sale ($430k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.00 | 10,000 | $210K | 48.9% |
| 2 | $21.95 | 10,000 | $220K | 51.1% |
| Total | $21.48 avg | 20,000 | $430K | 100% |
| Filing → |
| NBIX | SELL | 2017-01-18 | $142K | — | Filing → |
| NBIX | SELL | 2017-01-12 | $152K | — | Filing → |
| FATE | BUY | 2016-11-28 | $300K | — | Filing → |